Recent Developments in Contrast Media

Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast agents accumulate in tissues inside patients. This has raised concern because prolonged, elevated levels of gadolinium in the body may cause a nephrogenic systemic fibrosis in patients with severe kidney disease. Adding to this concern were three studies in 2015, which raised new gadolinium safety concerns after it was found the agent also accumulates in the brain

Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival

American College of Radiology Classifies VUEWAY as a Group II Agent Relative to NSF

The Future of Diagnostic Radiopharmaceuticals and Contrast Media: Emerging Trends and Technologies. by sayabonde - Issuu

Contrast Media Imaging Technology News

ITN Wins Jesse H. Neal Award for Best Technical Content

Ultrasound Contrast Agents: Basic Principles and Clinical Applications: 9781853178283: Medicine & Health Science Books @

Angiocardiography - Just H. (Curatore); Heintzen P.H. (Curatore)

PDF) Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma

MRI's Environmental Impact

Using Artificial Intelligence to Reduce Gadolinium Contrast

Trends in contrast media research the last 100 years - Yousef W Nielsen, Henrik S Thomsen, 2021

EHR Interventions for Contrast Media Shortage Impact CT Utilization